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ABSTRACT 
As the HIV population ages and HAART extends the life span of older HIV+ individuals, 
it is important to address the neuropsychological, cognitive, and emotional manifestations 
of HIV in this sub-population.  The purpose of the present study was to examine whether 
apathy and depressive symptoms were associated with executive functioning in older 
HIV+ individuals.  This archival study explored whether four items from the Beck 
Depression Inventory, Second Edition (BDI-II) could serve as an index of apathy and 
whether higher scores on these items would be related to greater impairment on measures 
of executive functioning.  The sample consisted of 95 older HIV+ persons who 
completed neurocognitive tests of executive functioning as well as the BDI-II as part of 
larger study examining the relationship between HIV and aging.  The measures of 
executive functioning were: the Stroop Color Word Interference Test; the Trail Making 
Test, Part B; the Controlled Word Association Test; and the Wisconsin Card Sorting 
Test-64.  Four items from the BDI-II - reflecting loss of pleasure, loss of interest, loss of 
interest in sex, and difficulty making decisions - were selected on the basis of prior 
research and rational analysis as likely to represent apathy.  Cronbach’s alpha reliability 
analysis determined that these four items of the BDI-II clustered together with acceptably 
high internal consistency in the present sample (.75).  However, overall scores on the 
BDI-II, including on the four items thought to reflect apathy, tended to be surprisingly 
low, indicating little self-reported depressive symptomatology.  Consistent with prior 
research, the overall BDI-II showed impressive internal consistency reliability in the 
present sample (.92).  It was predicted that higher apathy scores would be associated with 
poorer performance on measures of executive functioning.  The sample was ethnically 
   
 
 x 
diverse, predominantly male, and had a mean age of 55.26 years.  The mean years of 
education was 13.67, while the mean estimated level of premorbid intellectual 
functioning was 97.73.  The results showed there was no significant relationship between 
the hypothesized apathy items and executive functioning performance.  Moreover, 
findings showed no relationship between overall BDI-II scores and performance on 
measures of executive functioning.  The limitations of this archival study included the 
absence of an independent criterion measure for the construct of apathy.  Other findings, 
additional limitations, and suggestions for future research are discussed.  
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Introduction 
Background  
The Centers for Disease Control and Prevention (CDC, 2008) estimate that over 1 
million individuals in the United States are infected with the human immunodeficiency 
virus (HIV).  Since the introduction of highly active antiretroviral therapy (HAART), 
survival rates associated with HIV have improved dramatically (de Olalla et al., 2002; 
Murphy et al., 2001).  However, despite advances in the diagnosis and treatment of HIV 
infection, most antiviral treatments do not cross the blood-brain barrier (Gartner & Liu, 
2002; Gartner, 2000), leaving the CNS vulnerable to the damaging neurotropic effects of 
HIV (Ellis, Langford, & Masliah, 2007).  With the introduction of HAART, there has 
been a greater life expectancy for HIV infected persons, which has ultimately resulted in 
a growing population of older HIV+ individuals.  Progress in treatment has transformed 
HIV from an untreatable illness with a dire prognosis to a more chronic illness with 
complex cognitive and neuropsychiatric manifestations (Bornstein et al., 1993a; Gorman, 
Foley, Ettenhofer, Hinkin, & van Gorp, 2009; McCombe, Noorbakhsh, Buchholz, Trew, 
& Power, 2009; Starace et al., 2002).   
Neuropsychological Factors Associated With HIV  
Cognitive impairment has been found to occur in 55% to 65% of people with 
AIDS and it has been estimated that between 30% and 50% of HIV+ individuals would 
experience some form of neurocognitive decline (Heaton et al., 1995).  Despite treatment 
advances in the post-HAART era and reduced frequency of dementia, milder forms of 
cognitive impairment remain frequent (Antinori et al., 2007; Heaton et al., 2010).  HIV 
infection most prominently affects the cognitive domains of motor functioning, attention, 
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processing speed, executive functioning, and memory (Ances & Ellis, 2007; Foley, 
Ettenhofer, Wright, & Hinkin, 2008; Heaton et al., 1995; Woods, Moore, Weber, & 
Grant, 2009).  HIV-related neurocognitive impairment can range from subtle deficits to 
marked dementia syndromes that disrupt an individual’s daily functioning, employment, 
and ability to manage important tasks such as managing finances and adhering to 
medications (Foley et al., 2008; Gorman et al., 2009; Grant, Heaton, & Atkinson, 1995; 
Heaton & The HNRC Group, 2004; Hinkin, van Gorp, & Satz, 1995).  Although the 
specific mechanisms and effects of HIV infiltration of the CNS are not fully understood, 
there is research indicating that the frontal-subcortical circuitry is a primary target 
(Everall, Luthert, & Lantos, 1991; Heaton et al., 1995; von Giesen, Baecker, Hefter, & 
Arendt, 2001).  A recent study from Dawes and colleagues (2008) has shown that 
executive function impairment is a central characteristic of most HIV neurocognitive 
impairment profiles.  Executive functions include abstraction, problem solving, set 
shifting and reasoning.  Because executive functions are dependent on the frontal cortex, 
it makes sense that HIV has been found to be associated with executive function 
impairment (Reger, Welsh, Razani, Martin, & Boone, 2002).  Executive dysfunction has 
been found to be associated with functional deficits that include decreased medication 
adherence and poorer performance of activities of daily living (Schillerstrom, Horton, & 
Royall, 2005).  
Neuropsychiatric and Neurocognitive Disorder in Older HIV+ Adults 
Currently, more than 15% of all US AIDS patients are older than 50 years (CDC, 
2007).  With the introduction of more effective treatments, mortality rates have dropped 
and HIV has consequently evolved into a disease that is increasingly affecting older 
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adults (Valcour et al., 2004).  Research findings have supported the hypothesis that older 
HIV-infected individuals may be at greater risk for cognitive impairment due to the co-
occurrence of both older age and HIV disease (Becker, Lopez, Dew, & Aizenstein, 2004; 
Valcour et al., 2004).  Given that HIV infection and normal aging processes are risk 
factors for neuropsychological compromise, it is not surprising that the older HIV 
population is particularly vulnerable to neuropsychological impairment.  Research 
suggests that the clinical manifestations of infection among older HIV+ individuals are 
considerably different than those observed in younger cohorts, because of the increased 
risk factors and vulnerability for developing cognitive decline (Foley et al., 2008; 
Valcour et al., 2004).  It has also been suggested that neuropsychological deficits are 
more pronounced in the later stages of HIV infection (Heaton et al., 1995).  Therefore, 
neuropsychological tests may be important tools for detecting deficits present in an older 
HIV population, especially given that older individuals are more likely than younger 
persons to exhibit cognitive decline.  As the HIV population ages and HAART extends 
the life span of older HIV+ individuals, it is important to address the neuropsychological 
and cognitive manifestations of HIV in this sub-population.  The purpose of the present 
study was to examine whether the construct of apathy was associated with executive 
dysfunction in a sample of older HIV+ individuals.  To the extent that a relationship 
could be identified, it was reasoned that apathy may represent a significant 
neuropsychiatric indicator of CNS pathology among older HIV+ individuals. 
HIV and Depression 
Depression is common in individuals with a variety of medical illnesses, and 
appears to be more common among HIV+ individuals than the general population (Basu, 
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Chwastiak, & Bruce, 2005; Chandra, Desai & Ranjan, 2005; Treisman, Fishman, 
Schwartz, Hutton, & Lyketsos, 1998).  In the U.S., estimated prevalence of depression is 
2-10 times higher in people living with HIV/AIDS compared to the general population 
(Bing et al., 2001; Pence, 2009).  Bing and colleagues (2001) showed that as many as 
37% of HIV-infected individuals suffered from major depression.  Despite medical 
treatment advances, it remains unclear what factors are contributing to the high 
prevalence of depression among those with HIV.  While researchers have accumulated 
considerable findings regarding the cognitive consequences of HIV infection, less is 
known about the neuropsychiatric changes that often surface.  The degree to which mood 
disturbance may manifest differently in primary psychiatric versus primary neurologic 
populations has been under-studied.  The extent to which psychiatric features that 
accompany HIV, such as depression, anxiety, irritability, and apathy, are a result of 
insults to the CNS or secondary to medical, social, and financial stressors remains unclear 
(Castellon, Hinkin, & Myers, 2000; Castellon, Hinkin, Wood, & Yarema, 1998; Rabkin 
et al., 2000).  It has been suggested that the depression associated with HIV is either 
idiopathic or induced by the illness through direct or indirect pathways.  Idiopathic 
depression stems from factors that cause depression in non-medically ill populations, 
such as family history of affective disorders, trauma, or adverse life stressors.  HIV-
provoked depression implies that the mood disorder is either associated with the CNS 
infiltration of HIV or a response to increased stressors associated with HIV.  Treisman et 
al. (1998) suggest that depression may be the result of neurotropic effects of the virus on 
the subcortical brain areas that remain vulnerable with HAART treatment.  However, 
most research has found that among HIV+ individuals, depression and anxiety appear to 
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be less related to the neurotropic effects of the disease (Bornstein et al., 1993b; Carter, 
Rourke, Murji, Shore, & Rourke, 2003; Castellon et al., 1998; Cole et al., 2007; Heaton 
et al., 1995; Judd et al., 2005; Rabkin et al., 2000) and more likely stemming from 
secondary factors such as social stigmatization, marginalization, unemployment, 
bereavement, compromised social support, and increased medical, legal and financial 
stressors (Castellon et al., 2000; Grassi et al., 1999; Perez et al., 2005; Roberts, Ciesla, 
Direnfeld, & Hewitt, 2001).  In addition, it is likely that depression is higher among 
HIV+ individuals because it is idiopathic and comorbid with the risk factors that lead to 
HIV infection, such as substance abuse and risky sexual behaviors (Bing et al., 2001; 
Dausey & Desai, 2003).  In other words, depression may be a risk factor for contracting 
HIV and therefore precede actual infection.  Gorman and colleagues (2009) suggest that a 
bidirectional relationship may exist whereby symptoms of idiopathic depression 
precipitate secondary factors such as poor psychosocial, medical and financial adjustment 
in individuals with HIV.  Overall, a majority of the research postulates that depression is 
generally not caused by biological factors associated with HIV infiltration, but is rather 
idiopathic and/or a psychological response to the cognitive deficits and social stressors 
secondary to HIV.  
HIV and Apathy  
Apathy refers to a state of indifference and a reduction in self-initiated or goal 
directed thoughts and behaviors; it is frequently seen in CNS disorders that disrupt 
frontal-subcortical connections (Marin, 1991; van Reekum, Stuss & Ostrander, 2005).  
Specifically, apathy includes decreased work motivation, decreased social involvement, 
anhedonia, difficulty making decisions, and anergia.  Apathy has been more commonly 
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reported in patients infected with HIV than in the general population (Castellon et al., 
2000; Hinkin, Castellon, Atkinson & Goodkin, 2001; Rabkin et al., 2000).  Because 
patients with depression often have symptoms of apathy, it is difficult to distinguish 
apathy as a distinct syndrome or merely a symptom of depression (Levy et al., 1998).  
Nevertheless, apathy has been demonstrated to be qualitatively distinct from depression 
in HIV+ individuals (Castellon et al., 2006; 1998; Levy et al., 1998).  Research 
conducted with the HIV population has found symptoms of apathy rather than depression 
to correlate strongly with cognitive dysfunction (Castellon et al., 2006; Cole et al., 2007).  
In other words, apathy, unlike depression, may reflect a direct consequence of the HIV 
infection on the brain structures that regulate emotional reactivity.  It can be assumed that 
damage to the frontal area due to HIV infiltration has the potential to produce an 
apathetic state because this is the area of the brain involved in emotional experiences 
such as energy, enthusiasm, productivity, and initiative (Cummings, 1993; Levy et al., 
1998; Zamboni, Huey, Krueger, Nichelli, & Grafman, 2008).  Frontal lobe symptoms 
such as apathy have been attributed to disruption in subcortical circuits involving the 
basal ganglia and the frontal lobes (Landes, Sperry, Strauss, & Geldmacher, 2001).  
Therefore, manifestation of simultaneous apathy and cognitive deficits could be related to 
the underlying damage of subcortical and frontal systems.   
The relationship of apathy to neurocognitive function has been extensively 
studied in a range of brain disorders (van Reekum et al., 2005).  Research has shown 
apathy to be separate from depression and associated with neurocognitive impairment 
and neurological pathology seen in stroke, dementia, and Parkinson’s Disease 
populations (Brodaty et al., 2005; Engelborghs et al., 2006; Kuzis, Sabe, Tiberti, 
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Dorrego, & Starkstein, 1999; Levy et al., 1998; Oguru, Tachibana, Toda, Okuda, & Oka, 
2010; Pluck & Brown, 2002).   Among these brain disorders, there are a number of 
studies finding a consistent relationship between high levels of apathy and poor 
performance on tests representing executive function (Andersson & Bergedalen, 2002; 
McPherson, Fairbanks, Tiken, Cummings, & Back-Madruga, 2002; Zgaljardic et al., 
2007).  There is also research showing a relationship between apathy and executive 
functioning in populations with psychosis (Faerden et al., 2009).  In the Alzheimer’s 
Disease (AD) population, apathy is a common neuropsychiatric symptom and one of the 
primary neuropsychiatric manifestations of frontal system dysfunction (Boyle & Malloy, 
2004).  Cole and colleagues (2007) postulate that because AD and HIV populations have 
similarly elevated rates of apathy and irritability symptomatology, it further supports the 
theory that frontal system involvement is underlying the psychiatric manifestations in 
both populations.   
Research focusing on HIV populations suggests that apathy prominence among 
HIV+ individuals may signify disease associated CNS insult.  In the HIV population, 
disturbance of motivation and goal-directed behavior has been found to correlate with 
lower neurocognitive performance (Andersson & Bergedalen, 2002; Castellon et al., 
1998, 2000, 2006; Cole et al., 2007; Paul et al., 2005a).  Castellon et al. (2006) found 
prominent symptoms of apathy and irritability to be highly related to poorer performance 
on neuropsychological tasks most dependent upon executive functioning.  Paul and 
colleagues (2005a) similarly found that higher levels of apathy correlated with poor 
frontal systems functioning such as cognitive flexibility.  Neuro-imaging research has 
provided further preliminary evidence that apathy reflects direct involvement of the CNS 
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in patients with HIV (Hoare et al., 2010; Paul et al., 2005b).  Paul and colleagues (2005b) 
found that increased ratings of apathy were significantly correlated with lower volume of 
the nucleus accumbens, a subcortical brain structure that regulates initiation of behavioral 
activation.  All together these findings suggest that symptoms of apathy are likely 
attributable to the primary CNS effects of the HIV virus on frontal-subcortical circuits.  
Despite significant research on apathy and neurocognitive functioning in brain disorders, 
there is a lack of research in this area focusing on the HIV population and even less 
research focusing on older HIV+ individuals.  If apathy is a potential indicator of CNS 
pathology in medical illness, it is important to assess its presence and its correlates in 
aging HIV individuals.  
Beck Depression Inventory II 
The current study focused on the “apathy” items of the second revised version of 
the Beck Depression Inventory (BDI-II; Beck et al., 1996).  The BDI-II was developed 
for the assessment of depressive symptoms that correspond to the Diagnostic and 
Statistical Manual of Mental Disorders-IV (DSM-IV; APA, 1994) criteria for major 
depressive disorder.  Although the BDI-II is meant to measure the global construct of 
depression, the question as to whether meaningful groups of items in the questionnaire 
can be discerned through factor analysis has been of ongoing interest (Beck et al., 1996).  
Studying the factors that underlie the depression construct is important because recent 
research indicates that sub-dimensions of depression have different correlates (Vanheule, 
Desmet, Groenvynck, Rosseel, & Fontaine, 2008).  
Castellon and colleagues (2006) conducted a factor analysis of the BDI on a large 
sample of HIV-infected individuals and found that certain items of the depression rating 
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scale consistently clustered together to form meaningful factors.  Specifically, they found 
three factors that were labeled Mood-Motivation Disturbance, Self-Reproach, and 
Somatic Disturbance.  Interestingly, these factors were found to be differentially 
associated with cognitive function in their HIV/AIDS sample.  The Self-Reproach factor 
contained items representing negative cognitions.  The Mood-Motivation Disturbance 
factor contained items related to apathy, sad mood and irritability.  The Somatic 
Disturbance factor contained items related to somatic complaints.  Specifically they 
found that the Mood-Motivation Disturbance factor, which consisted of 7 items reflecting 
symptoms of apathy, sad mood, and irritability, was the factor most strongly associated 
with neurocognitive performance.  In addition, they found that the neurocognitive 
domains most closely associated with the Mood-Motivation Disturbance factor were 
verbal memory, executive functioning, and motor performance.  The findings indicate 
that the apathy, irritability, and sad mood items from the BDI may be more indicative of 
CNS dysfunction than other items.  It was found that disturbance in mood and 
motivation, more so than negative self-view or somatic disturbance, was related to 
neurocognitive deficits.  
The current study focused specifically on items within the BDI-II that were 
believed to reflect symptoms of apathy.  Items of interest in the current study were 
comparable to only the apathy items belonging to the Mood-Motivation Disturbance 
factor found in the Castellon 2006 study and found to load together in prior research on 
the BDI (e.g. Startup, Rees & Barkham, 1992; Steer, Beck, Riskind, & Brown, 1987; 
Tanaka & Huba, 1984).  The BDI apathy related items found to load together in prior 
research included (a) decreased work initiative, (b) decreased social initiative, (c) 
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anhedonia, (d) difficulty making decisions, and (e) anergia.  In the current study, 
symptoms of sad mood and irritability were not evaluated because the researcher was 
specifically evaluating the apathy component of depression.  Even though the current 
study examined the BDI-II rather than the original BDI, those items reflecting symptoms 
of apathy have generally remained unchanged in the revised scale.  The BDI was merely 
modified to better complement the DSM-IV criteria for major depressive disorder (Beck, 
Steer, Ball, & Ranieri, 1996).  Items of the BDI-II reflective of apathy symptoms include 
(a) Loss of pleasure (item 4); (b) Loss of interest (item 12); (c) Difficulty making 
decisions (item 13); and (d) Loss of energy (item 15).  The BDI-II item of Loss of 
Interest replaced the BDI items relating to social withdrawal to emphasize withdrawal 
from both interpersonal relationships and activities.  In addition, the BDI-II item of Loss 
of Pleasure replaced the BDI items related to loss of satisfaction and anhedonia.  The 
item related to difficulty making decisions remained unchanged.    
Recent research has indicated that it is important to consider overlapping 
symptoms of HIV disease and somatic symptoms of depression that can inflate scores on 
depression inventory instruments (Kalichman, Rompa, & Cage, 2000).  Kalichman and 
colleagues (2000) found that removing somatic depression symptoms improved the 
clinical utility of the BDI in an HIV+ sample.  Their findings suggest that clinicians 
should be cautious regarding somatic symptoms when evaluating depression scores in 
people living with HIV infection.  It has been suggested that somatic symptoms included 
in most depression measures might be indicators of physical illness, and therefore, 
diagnostically ambiguous (Castellon et al., 1998).  Castellon and colleagues (1998) 
argued that unlike the somatic symptomatology of depression, the affective/cognitive 
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symptomatology of depression is a more accurate indicator of mood disturbance among 
medically ill individuals.  Therefore, in the current study, somatic symptoms overlapping 
with medical illness symptoms, such as fatigue and loss of energy, were not evaluated 
within the context of apathy because they were considered to be diagnostically 
ambiguous in a medically ill population.  Specifically, the BDI-II items of Loss of Energy 
and Fatigue were not evaluated in terms of apathy.  However, these items were included 
in our evaluation of overall depression, because somatic symptoms are a significant 
component of depression.   
Overall, prior research has shown that while apathy and depression are 
overlapping dimensions, they can nevertheless be distinguished from one another and can 
differentially influence cognitive functioning (Castellon et al., 2006, 1998).  However, 
among HIV patients, it remains unclear whether the symptoms of apathy within 
depression reflect a direct effect of the virus on subcortical brain circuits or reflect more 
of a secondary neuropsychiatric manifestation. 
Purpose of the Study 
Many studies have failed to find a consistent relationship between mood and 
neurocognitive performance among HIV+ individuals (e.g., Bornstein et al., 1993b; 
Hinkin et al., 1992; von Giesen et al., 2001).  However, most studies to date have focused 
on depression rather than more specific and differentiated components of depression such 
as apathy.  In addition, those few studies that have focused on apathy in HIV populations 
have studied relatively young persons.  Prior research has yet to focus on the relationship 
between apathy and cognition in a sample of older HIV+ individuals.  The aim of the 
current study was to expand on the prior research on apathy in HIV populations and 
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improve our understanding of apathy in relation to executive functioning in older HIV+ 
individuals.  This study explored the concept of mood disturbance in HIV populations by 
breaking down a traditional measure of depression (BDI-II) and examining the items 
believed to be reflective of apathy, including their relationship to executive functioning.  
To the researcher’s knowledge, no prior research existed that utilized the BDI-II to 
explore apathy symptomatology and its relationship to cognitive functioning in an older 
HIV+ population or any other population.  This study aimed to determine whether 
specific BDI-II items representing symptoms of apathy could be clustered into a 
component of depression analogous to apathy and whether executive functioning 
performance would differ between those scoring high and low on this cluster.   
The following research questions and hypotheses were addressed.  First, to what 
extent do the apathy items of the BDI-II group together in a sample of older HIV+ 
individuals?  It was hypothesized that the BDI-II apathy items would cluster together 
with an internal consistency of .70 or higher.  Next, how do the BDI-II apathy items 
relate to executive functioning performance in older HIV+ individuals?  It was 
hypothesized that persons scoring high on the apathy items would perform more poorly 
on executive function tasks than persons scoring low on the apathy items.  In other 
words, it was predicted that scores on the BDI-II apathy cluster would be inversely 
related to executive functioning performance.  The third research question was as 
follows: what is the relationship of BDI-II total scores to executive functioning 
performance in older HIV+ individuals?  It was expected that overall BDI-II scores 
would have an inverse relationship to executive functioning, but the association was 
expected to be weaker than that shown with the four BDI-II apathy items.   
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Method 
Design 
This study was a secondary analysis of primary data gathered from an ongoing 
longitudinal, case-control study aiming to determine the effect of age on 
neuropsychological performance in HIV+ persons. The nature of the design was 
essentially correlational in that the researcher examined the extent to which one factor, 
i.e., the apathy items on the BDI-II, corresponded to aspects of executive functioning in a 
sample of older HIV+ persons.  
Participants 
Subjects for this study were recruited from the West Los Angeles Veterans 
Administration Medical Center and other community agencies and medical centers in the 
Los Angeles area specializing in serving HIV-infected individuals.  Patients were eligible 
for the parent study if they were between the ages of 18-40 years or 50 years and older.  
In addition, participants had to document presence or absence of HIV infection 
(depending on their group assignment) and had to be proficient in English.  Any 
participants showing evidence of opportunistic infection or central nervous system (CNS) 
infection other than HIV were excluded.  In addition, participants were excluded if they 
had a history of traumatic brain injury with loss of consciousness greater than 30 minutes, 
a current diagnosis of seizure disorder, or a current psychotic spectrum disorder (e.g., 
schizophrenia, bipolar disorder).  Patients meeting inclusion criteria were scheduled for 
an initial visit.  All subjects were tested as outpatients.  Approval to conduct the original 
study was granted by the University of California, Los Angeles and the Veteran’s 
Administration Institutional Review Boards. 
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Additional exclusion criteria were utilized for the present study.  Subjects were 
excluded if they were under the age of 50.  Subjects were also excluded if they presented 
with medical co-morbidities unrelated to HIV, which may increase risk for cognitive 
impairment (e.g., brain anoxia, stroke).  In addition, we excluded participants who tested 
positive for cocaine or amphetamines on their initial visit urine screen and simultaneously 
met criteria for drug dependence over the last 30 days according to self-report.  These 
exclusion criteria were utilized to ensure a clean sample of older HIV+ individuals.  In 
other words, the researcher was attempting to control for factors other than apathy that 
could account for variance in cognitive performance.  The researcher was aware that this 
would impact generalizability, given that HIV+ individuals often possess a number of the 
comorbid conditions listed in our exclusion criteria.  However, the aim of this study was 
to determine whether apathy, in the absence of other influential factors, could be found to 
be associated with deficits in executive functioning.  Given the assumption of a medium 
effect size, a sample size of 64 total was determined to be sufficient to detect the presence 
of significant differences at an alpha level of 0.05 (Cohen, 1992) 
Neurocognitive Measures  
In the current study, four instruments were used to measure executive functioning.  
The Stroop Color Word Interference Test (Stroop, 1935) assesses multiple functions 
including color-naming and word-reading speed, sustained attention, and, in the 
interference condition, selective attention and the ability to inhibit a habitual response in 
favor of a more over learned response.  It is an overall measure of selective attention and 
cognitive flexibility.  The current study utilized the Golden version of this test (Golden, 
1978).  In the color-word interference condition the subject reads the color in which color 
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names are printed and disregards their verbal content.  The dependent variable of interest 
is the number of trials completed in 45 seconds for this color-word interference condition.  
High test-retest reliability coefficients have been reported for the Golden version of the 
Stroop (Connor, Franzen, & Sharp, 1988; Franzen, Tishelman, Sharp, & Friedman, 
1987).  In addition, it has been found that the interference score correlates moderately 
well with other measures of attention (MacLeod & Prior, 1996; Weinstein, Silverstein, 
Nader, & Turnbull, 1999) and neuroimaging studies have shown that the frontal lobe is 
the most consistent region of activation during this test (Brown et al., 1999; Mead et al., 
2002).   
The Trail Making Test (Reitan, 1958) is a brief test of visual-motor function, 
attention, and psychomotor speed.  Part B of this task requires switching conceptual set 
(alternating between connecting numbers and letters in ascending sequence) and 
measures number-letter switching ability.  This test has been shown to be a valid measure 
of cognitive impairment (Bradford, 1992; Gaudino, Geisler & Squires, 1995) and to have 
high interrater reliability (Fals-Stewart, 1992).  For this particular study, only Part B 
performance was examined and the dependent variable of interest was the completion 
time in seconds for Part B.   This test indicates one’s ability to execute and modify a plan 
of action, and has been found to be sensitive to frontal lobe damage (Boll, 1981; Lezak, 
Howieson & Loring, 2004).  Studies have found that cognitive flexibility, also referred to 
as “attentional set-shifting,” could capture executive abilities underlying Part B 
performance (Chaytor, Schmitter-Edgecombe, & Burr, 2006; Kortte, Horner, & 
Windham, 2002).   
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The Controlled Oral Word Association Test (Benton, Hamsher, Varney & Spreen, 
1983) assesses semantic and phonemic verbal fluency.  Over the course of three, one-
minute trials, the subject must name as many words as he or she can starting with a given 
letter (“F”, “A”, and “S”) and, in the final one-minute trial, he or she must name as many 
types of animals as possible. This test has been shown to have high test-retest reliability 
(Levine, Miller, Becker, Selnes, & Cohen, 2004), high interrater reliability (Ross, 2003) 
and good validity (Troyer, 2000).  In the current study, only phonemic (FAS) 
performance was examined and the dependent variable of interest was the total number of 
words generated.  The verbal fluency test has been described as an executive function test 
(Lezak et al., 2004).  Moreover, research has shown that patients with frontal damage 
produced significantly fewer responses on verbal fluency tests compared with patients 
with lesions in other brain areas (Perret, 1974).  
The Wisconsin Card Sorting Test (WCST; Grant & Berg, 1948) is widely 
regarded as a valid test of frontal lobe functioning (Robinson, Heaton, Lehman, & 
Stilson, 1980; Lezak et al., 2004) with generally strong test-retest reliability (Tate, 
Perdices, & Maggiotto, 1998).  The WCST assesses abstract reasoning, problem solving 
and the ability to adapt cognitive strategies to external changing feedback (Chelune & 
Baer, 1986).  The dependent variable of interest in the current study was the number of 
perseverative errors on the WCST-64 computer version of this test - an abbreviated form 
of the standard 128-card version of the WCST (Kongs, Thompson, Iverson, & Heaton, 
2000).  A perseverative error refers to the number of errors in which the participant 
perseverates on a prior matching strategy, reflecting failure to shift to the new sorting 
criterion.  Among the various scoring norms of the WCST, perseverative errors are 
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regarded as the main signs of frontal dysfunction (Greve, Stickle, Love, Bianchini, & 
Stanford, 2005).  
Neuropsychiatric Measure 
The Beck Depression Inventory, 2nd Edition (BDI-II; Beck et al., 1996), a 21-item 
self-report rating scale containing questions pertaining to the presence and intensity of 
various cognitive, affective, and somatic symptoms of depression over a two-week 
period, was administered to all participants.  Each item is a list of four statements 
arranged in increasing severity about a particular symptom of depression.  There is a 
four-point scale for each item ranging from 0 (symptom absent) to 3 (presence of 
symptom is pronounced).  Each of the 21 items is summed to give a single score for the 
BDI-II.  Cut score guidelines for the BDI-II are as follows: Total score of 0-13 is 
considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.  The 
timeframe and items are aligned with depression criteria of the DSM-IV.  The test 
requires a 5th to 6th grade reading level (Groth-Marnat, 2009) and is intended for persons 
13 years of age and older.  According to test authors, the BDI-II demonstrated internal 
consistency reliability of .92 in a sample of 500 psychiatric patients, and test-retest 
reliability (one week interval) of .93 in a small sample of outpatients (Beck et al., 1996).  
Evaluations of the content, concurrent, and discriminant validity of the BDI-II have been 
impressive, and over 1,000 research studies have employed a version of the Beck 
Depression Inventory (Groth-Marnat, 2009).  
Research has indicated that the BDI-II is a reliable and valid measure of 
depression for use in outpatient medical populations, including among ethnically and 
socioeconomically diverse communities (e.g., Jarjoura et al., 2004; Joe, Woolley, Brown, 
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Ghahramanlou-Holloway, & Beck, 2008; Groth-Marnat, 2009; Grothe et al., 2005).  It 
has also been used with diverse samples of HIV+ individuals (e.g., Weiser et al., 2006) 
and has been found to be a sufficiently reliable and valid measure for assessing 
depression in an HIV positive sample (Lipps et al., 2010).  Therefore, the BDI-II was 
determined be an appropriate measure of depressive symptoms in the present sample. 
The apathy variable of interest in the current study consisted of the following 
items of the BDI-II: (a) Loss of Pleasure (item 4); (b) Loss of Interest (item 12); (c) 
Indecisiveness (item 13); and (d) Loss of Interest in Sex (item 21).  To the researcher’s 
knowledge, there had been no published research attempts to examine the apathy items of 
the BDI-II prior to the current study.  Therefore, the current study aimed to look 
specifically at items that were comparable to those items previously found to load 
together in the original BDI and to be reflective of disturbance in motivation (Castellon et 
al., 2006; Startup et al., 1992; Steer et al., 1987; Tanaka & Huba, 1984).  Five of the 
seven original BDI items in the Mood-Motivation Disturbance factor identified by 
Castellon and colleagues (2006) appeared reflective of apathy.  Those items addressed 
included decreased work initiative, decreased social initiative, anhedonia, difficulty 
making decisions, and anergia.  Those items appeared similar to items found on 
established apathy scales (e.g., The Apathy Evaluation Scale-Self Report Version; Marin, 
1991).  In the current study, somatic symptoms overlapping with medical illness 
symptoms, such as fatigue and loss of energy, were not evaluated within the context of 
apathy because they were considered to be diagnostically ambiguous in a medically ill 
population.  Items of interest were cognitive-affective and directly correspond to the 
“apathy” items found in previous research on the BDI.  Therefore, items reflective of the 
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anergia item from the earlier BDI research were not included among the apathy-related 
BDI-II items selected for study in the present investigation.  Loss of Interest in Sex was 
included in the present “apathy” construct because it inquires about interest in sexual 
activity rather than changes in sexual activity.    
Procedures 
All participants completed a comprehensive neuropsychological test battery 
between the years of 2005 and 2010 at the West Los Angeles Veterans Administration 
Medical Center.  The battery was administered by trained psychometrists who were 
supervised by a board certified neuropsychologist.  The neuropsychological evaluation 
was extensive and included multiple performance measures of several cognitive domains.  
Participants’ sociodemographic data, HIV status and health information (e.g., viral load, 
CD4 count, medications, duration of illness, and health conditions) were obtained once 
informed consent had been established.  Participants completed all screens, 
questionnaires, and neuropsychological tests within a one-day period.  Initial visit 
duration was typically 6-7 hours and participants were financially compensated $90.00 at 
the end of the day.  
The current study examined a sub-sample of Visit 1 data that included 
neurocognitive test results, specifically in the domain of executive functioning, as well as 
BDI-II scores, and demographic information.  The current study only examined the older 
age group (older > 50 years).  Neurocognitive test scores were converted to 
demographically adjusted T-scores (M = 50, SD = 10), including adjustments for age, 
education, gender, and ethnicity as available for each test.  In other words, when 
demographic specific norms were available for a test, T-scores were calculated based on 
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comparisons to norm groups that shared similar demographic characteristics.  
Specifically, scores obtained from the Trails B and FAS tests were corrected based on 
age, education, gender and race/ethnicity (Heaton, Miller, Taylor, & Grant, 2004).  
Scores obtained from the WCST-64 were adjusted based on age, education, gender and 
race/ethnicity (Kongs et al., 2000).  Scores for the Stroop C test were demographically 
adjusted for age only (Golden, 1978).  The T-scores of tests expected to represent 
executive functioning were averaged into one score that was meant to reflect the 
construct or variable, “executive function”.  The researcher was granted approval from 
Pepperdine University’s Graduate and Professional Schools Institutional Review Board 
(GPS IRB) subsequent to submitting the proposal for consideration and review. 
Data Process and Analysis  
The Statistical Package for the Social Science (SPSS) version 18.0 was used for 
all data analyses.  For the first research question, a Cronbach’s alpha reliability analysis 
was conducted to determine whether the four apathy items of the BDI-II would cluster 
together into a component that could reasonably and meaningfully be viewed as 
representing apathy.  An internal consistency value of 0.7 or higher was expected to 
indicate that these items adequately cluster together.  This cluster of BDI-II items was 
summed and labeled as “Apathy”.  For the second research question, the researchers 
divided the sample into two groups labeled “Low Apathy” and “High Apathy”.  In an 
effort to maximize apathy differences, the original plan was for the groups to be 
dichotomized by their Apathy scores as follows: Low Apathy < 33rd percentile; High 
Apathy > 67th percentile.  Those individuals scoring between the two cut-offs were not to 
be included in the analysis.  This was expected to allow sufficient discrimination to 
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adequately differentiate between the Low and High Apathy groups.  Excluding those 
individuals scoring between the 33rd and 67th percentile was meant to control for the 
ambiguity that arises when creating groups based on cut-off scores or median splits.  As 
is described in the Results chapter, the cut-offs had to be adjusted to fit the obtained data.     
The executive function variable of interest in the current study consisted of the 
average of T scores from the four chosen “executive function” measures.  A one-way 
ANOVA was run to determine whether the High Apathy group had significantly lower 
executive functioning performances than the Low Apathy group.  For the final research 
question, we divided the sample into two groups based on a cluster of total BDI-II items.  
We labeled these two groups “Low Depression” and “High Depression”.  In an effort to 
maximize depression differences, the original plan was for the groups to be dichotomized 
by their BDI-II total scores as follows: Low Depression < 33rd percentile; High 
Depression > 67th percentile.  Those individuals scoring between the two cut-offs were 
not to be included in the analysis.  As described in the Results chapter, the cut-off had to 
be adjusted slightly for the Low Depression group in order to better fit the present data.  
A one-way ANOVA was run to determine whether the High Depression group had 
similar executive function scores compared to the Low Depression group.  Finally, 
correlations were calculated to assess the relationships between executive functioning 
performance and each of the three components of the BDI-II that were being examined 
(e.g. Apathy, Non-Apathy, Depression).  To determine the correlations between normally 
distributed continuous variables, Pearson’s r was utilized.  
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Results 
The total sample consisted of 95 individuals.  As can be seen in Table 1 and Table 
2, on average, the participants who met the inclusion criteria were 55.26 years old (SD = 
5.85), had a lowest CD4 count of 191.04 (SD = 198.11) and had an educational level of 
13.67 years (SD = 2.20).  On the Wechsler Test of Adult Reading (WTAR; The 
Psychological Corporation, 2001), a reading test that estimates pre-morbid level of 
intellectual functioning, the participants had a mean standard score of 97.73 (SD = 
17.19), reflecting an average performance.  Table 3 presents the mean values on measures 
of executive functioning.  Consistent with the WTAR finding, participants obtained an 
overall mean T score of 45.33 (SD = 9.25) on the executive functioning measures, 
indicating that performance fell in the average range.  
As indicated in Table 2, the sample was diverse in terms of ethnicity and sexual 
orientation.  The following frequencies were obtained regarding ethnicity: African 
American (n = 52), Caucasian (n = 30), Hispanic (n = 10), and Biracial (n = 1).  In regard 
to sexual orientation, the participants self-identified as follows: heterosexual (n = 43), 
homosexual (n = 37) and bisexual (n = 15).  A majority of the sample had low levels of 
household income: less than $12,000 (n = 51); $12,000 to 49,999 (n = 35); $50,000 or 
more (n = 7).  A majority of participants were male (n = 80) and reported English as their 
first language (n = 85).  All participants were proficient in English and were positive for 
HIV.  
The mean Apathy score of the sample was 2.21 (SD = 2.17) with Apathy scores 
ranging from 1 to 8.  The mean BDI-II score of the sample was 10.22 (SD = 8.67) with 
scores ranging from 0 to 35.  Using the cut-off scores empirically established by Beck 
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and colleagues (1996), approximately 72% of the sample scored in the range considered 
as non-depressed (0-13), 11.6% in the range considered mild depression (14-19), 13% in 
the range considered moderate depression (20-28) and 3.3% in the range labeled as 
severe depression (29-63).    
A Cronbach’s alpha reliability analysis was conducted to determine whether the 
chosen four apathy items of the BDI-II clustered together into a component that could 
reasonably viewed as representing apathy.  Analysis determined that these items did 
cluster together with a value greater than 0.7 (α = 0.748).   
In order to dichotomize the low apathy and high apathy groups, our plan was to 
use 33rd/67th percentile cutoffs to adequately differentiate between the groups.  Of the 
sample, 48.9% (n = 46) had an Apathy score of 1 or lower (M = 0.41, SD = 0.5) and met 
our revised cut-off criterion for the Low Apathy group while 39.5% (n = 37) of the 
sample had an apathy score of 3 or higher (M = 4.51, SD = 1.5) and met our revised cut-
off criterion for the High Apathy group.  The mean apathy score for the Low Apathy 
group was 0.41 (SD = .5) and the mean apathy score for the High Apathy group was 4.5 
(SD = 1.5).  It was examined whether the High Apathy group differed from the Low 
Apathy group in terms of executive functioning performance.  We used an alpha level of 
0.05 for all statistical tests.  As can be seen in Table 4, a one-way ANOVA, comparing 
the High Apathy and Low Apathy groups revealed that the High Apathy subjects were no 
more impaired on the executive functioning measures (M = 44.87, SD = 9.17), than were 
Low Apathy subjects (M = 45.59, SD = 10.03), t(1,80) = 0.11, p = 0.74.  Therefore, the 
hypothesis that higher levels of apathy would be associated with greater impairment in 
executive functioning was not supported.  
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As can be seen in Tables 5 and 6, the Low Apathy and High Apathy groups did 
not differ significantly in age, lowest T-cell counts or educational level, and gender, 
income and ethnicity distributions were roughly equivalent.  Of note, a difference right at 
the threshold of statistical significance was found in pre-morbid intelligence as measured 
by the WTAR with the High Apathy subjects having a lower WTAR standard score (M = 
93.49, SD = 18.61) than the Low Apathy subjects (M = 101.16, SD = 16.08), t(1,79) = 
3.96, p = 0.05.   
A Cronbach’s alpha reliability analysis was conducted to establish the internal 
consistency of the BDI-II with the present sample.  The analysis confirmed a high level 
of internal consistency reliability (α = 0.92), similar to the values reported in the BDI-II 
manual (Beck et al., 1996).  In order to dichotomize the low depression and high 
depression groups, our plan was to use 33rd/67th percentile cutoffs to differentiate the 
between the groups.  Of the sample, 31% (n = 30) had a BDI-II score of 4.0 or lower (M 
= 1.90, SD = 1.49) and met our revised cut-off criterion for the Low Depression group, 
while 33% (n = 31) had a BDI-II score of 12 or higher (M = 20.39, SD = 6.37), and met 
our cut-off criterion for the High Depression group.  It was examined whether the High 
Depression group differed from the Low Depression group in terms of executive 
functioning performance.  As can be seen in Table 7, a one-way ANOVA, comparing the 
High Depression and Low Depression groups, revealed that the High Depression subjects 
were no more impaired on the executive functioning measures (M = 45.32, SD = 9.49), 
than were Low Depression subjects (M = 44.09, SD = 10.95), t(1,59) = 0.22, p = 0.64.   
To determine whether apathy and depression scores might be differentially 
associated with executive functioning performance in HIV-infected adults, we calculated 
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Pearson’s r correlations between three different BDI-II scores (apathy items, total score, 
and non-apathy related items) and the composite score of executive function.  As can be 
seen in Table 7, and contrary to what the researcher expected, neither apathy nor overall 
depression scores were significantly correlated with executive functioning performance.  
Specifically, the correlations between executive functioning and the four-item BDI-II 
apathy cluster (r = -0.02) and between executive functioning and the total BDI-II score (r 
= 0.04) were not significant.  Moreover, non-apathy depression items from the BDI-II 
were also found to be unrelated to the executive function variable (r = 0.03).   
Additional Analysis 
 The HIV+ individuals (n = 9) who were excluded from the present study were 
analyzed to determine whether those individuals had greater cognitive impairment and/or 
mood symptoms compared to the individuals who met inclusion criteria.  The mean 
Apathy score of the exclusion group was 2.33 (SD = 2.00) with Apathy scores ranging 
from 0 to 6.  The mean BDI-II score of this group was 12.67 (SD = 9.95) with scores 
ranging from 0 to 29.  On the executive functioning measures, these individuals obtained 
an overall mean T score of 45.50 (SD = 9.48), reflecting a performance falling in the 
average range.  These data are similar to those of the inclusion group indicating that the 
HIV+ persons excluded from the sample were no more cognitively impaired or 
neuropsychologically symptomatic than individuals who met the study’s inclusionary 
criteria.  
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Table 1 
Demographic Characteristics of Total Sample (N = 95) 
 
Variable 
Total Sample 
Mean SD 
Age 55.26 5.85 
Education 13.67 2.20 
Lowest CD4 Count 191.04 198.11 
Apathy Score 2.21 2.17 
Depression Score 10.23 8.67 
WTAR Standard Score 97.73 17.19 
 
Table 2 
Demographic Characteristics of Total Sample (N = 95) 
 
Ethnicity 
N  % 
  
   American Indian/Alaskan 1  1.05 
   Asian/Pacific Islander 1 1.05 
   Black 52 54.74 
   Hispanic 10 10.52 
   White 30 31.58 
   Other/Multiracial 1 1.05 
Sex    
   Male 80 84.21 
   Female 15 15.79 
English as First Language   
   No 10 10.53 
   Yes 85 89.47 
Sexual Orientation   
   Heterosexual 43 45.26 
   Homosexual  37 38.95 
   Bisexual 15 15.79 
Household Income   
   Less Than $6,000 13 13.68 
   $6,000 to $11,999 38 40 
   $12,000 to $24,999 27 28.42 
   $25,000 to $49,999 8 8.42 
   $50,000 or more 7 7.37 
   Refused To Answer 1 1.05 
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Table 3 
Executive Function Test Scores of Total Sample (N = 95) 
 
Variable 
Total Sample 
Mean SD 
Executive Function Score 45.33 9.25 
Trails B  45.84 12.92 
FAS Total  48.54 11.00 
Stroop Color/Word 44.23 8.56 
WCST 64 Perseverative 
Errors  
46.13 10.34 
 
Table 4 
Executive Function Score Means for Low Apathy (n =46) and High Apathy (n = 37) 
Subjects 
 
 
Apathy  
Low High F Sig 
Executive 
Function Score 
45.59 
(10.03) 
44.87 
(9.17) 
0.11 0.74 
Trails B  47.04 
(14.11) 
44.56 
(12.15) 
.70 .40 
FAS Total  49.31 
(12.19) 
47.61 
(9.95) 
.46 .50 
Stroop Color/Word 43.30 
(7.63) 
45.11 
(9.71) 
.86 .36 
WCST 64 
Perseverative 
Errors  
46.70 
(12.19) 
45.92 
(8.13) 
.11 .74 
Standard deviations appear in parentheses below means.  
 
Table 5 
Demographic Characteristics of Low Apathy (n = 46) and High Apathy (n = 37) Subjects 
 
 
Apathy  
Low High F sig 
Age 56.78 
(7.27) 
54.32 
(3.80) 
3.46 0.07 
Education 13.78 
(2.32) 
13.57 
(2.21) 
.18 .67 
Lowest CD4 218.86 
(220.63) 
170.67 
(164.21) 
1.18 .28 
WTAR Standard 
Score 
101.16 
(16.08) 
93.49 
(18.61) 
3.96 0.05 
Standard deviations appear in parentheses below means.   
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Table 6 
Demographic Characteristics of Low Apathy (n = 46) and High Apathy (n =37) Subjects 
 Low Apathy   High Apathy  
 
Ethnicity 
 N % N %  sig 
    .625 
   American 
Indian/Alaskan 
0 0 1 2.7 
   Asian/Pacific 
Islander 
0 0 1 2.7 
   Black 26 56.52 19 51.35 
   Hispanic 4 8.7 4 10.81 
   White 15 32.61 12 32.43 
   Other/Multiracial 1 2.17 0 0 
Sex      .451 
   Male 39 84.78 29 78.38 
   Female 7 15.22 8 21.62 
Sexual Orientation      
   Heterosexual 20 43.48 20 54.05 .56 
   Homosexual  18 39.13 13 35.14  
   Bisexual 8 17.39 4 10.81  
Household Income      
   Less Than $6,000 5 10.87 6 16.67 .13 
   $6,000 to $11,999 23 50 10 27.78 
   $12,000 to 
$24,999 
11 23.91 14 38.89 
   $25,000 to 
$49,999 
1 2.17 4 11.11 
   $50,000 or more 5 10.87 2 5.56 
   Refused To 
Answer 
1 2.17 0 0 
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Table 7 
Executive Function Score Means for Low Depression (n =30) and High Depression (n 
=31) Subjects 
 
 
Depression  
Low High F sig 
Executive 
Function Score 
44.09 
(10.94) 
45.32 
(9.49) 
0.22 0.64 
Trails B  44.83 
(13.80) 
46.47 
(10.17) 
.29  .59 
FAS Total  48.91 
(12.40) 
47.67 
(10.42) 
.19 .66 
Stroop Color/Word 42.21 
(7.57) 
44.73 
(9.73) 
1.33 .25 
WCST 64 
Perseverative 
Errors  
43.85 
(10.83) 
46.90 
(9.03) 
1.49 .23 
Standard deviations appear in parentheses below means.   
 
Table 8 
Correlations between the Mean Executive Function Score and the BDI-II Apathy, Non-
Apathy-Related Items, and Overall Depression Scores (N = 95) 
  Executive Function Score 
Apathy Items Pearson’s Correlation 
Sig. (2-tailed) 
 
-0.02 
.87 
Non-Apathy Items Pearson’s Correlation 
Sig. (2-tailed) 
 
0.04 
0.7 
Overall BDI-II Depression Pearson’s Correlation 
Sig. (2-tailed) 
 
0.03 
0.77 
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Discussion 
Overview 
The present study sought to examine the relationship between apathy and 
executive functioning among HIV-infected adults.  Additional but related aims were to 
examine whether specific items of the BDI-II thought to be reflective of apathy would 
cluster together, and whether there would exist an association between that cluster score 
and executive functioning performance in a sample of HIV-infected persons.  Although 
apathy in relation to neurocognitive functioning has been evaluated among HIV 
populations (Anderson & Bergedalen, 2002; Castellon et al., 1998, 2000, 2006; Cole et 
al., 2007; Paul et al., 2005a), this appeared to be the first study to focus on an older 
population and to specifically examine individual items of the BDI-II thought to be 
related to apathy.   
Internal Consistency of BDI-II Apathy Items 
We hypothesized that the chosen BDI-II items representing apathy would cluster 
together, and those endorsing a higher number of these items would have lower executive 
functioning scores compared to those endorsing a lower number of apathy items.  The 
results supported the hypothesis that the BDI-II apathy items would cluster together with 
an internal consistency of .70 or higher.  While this was an encouraging finding, it must 
be noted that the entire BDI-II has a high level of internal consistency.  In fact, the 
overall internal consistency of the BDI-II was approximately .92 in the present sample.  
Therefore, the encouraging level of internal consistency among the four items selected 
for study could not be viewed as definitive evidence that those four items were in fact 
measuring the construct of apathy.  A limitation of the present study, which is discussed 
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further later in this chapter, was that there was no independent measure of apathy that 
could be utilized to confirm the extent to which the four BDI-II items represented an 
adequate measure of the construct of apathy.       
Relationship of BDI-II Apathy Items to Executive Functioning 
The central hypothesis that persons scoring higher on the apathy items would 
perform more poorly on executive functioning tasks than persons scoring lower on the 
apathy items was not supported.  Inconsistent with our hypothesis, we found that there 
was no difference in executive functioning performance between those scoring high on 
our apathy construct and those scoring low on this construct.  Therefore, these results do 
not support the proposition that there is an aspect of depression, similar to apathy and 
measured by four items from the BDI-II, which is involved with frontal lobe neurological 
functioning (as measured by neurocognitive tests of executive functioning).  Moreover, 
correlational analysis likewise revealed there was no significant relationship between our 
four apathy items and executive functioning in the present sample.  
Relationship of BDI-II to Executive Functioning  
Data analysis revealed that there was no significant relationship between BDI-II 
total scores and executive functioning performance in the present sample.  In other 
words, we did not find a relationship between depressive symptoms and executive 
functioning.  Overall, the sample demonstrated average intellectual functioning, over 13 
years of mean education, and relatively low levels of depressive symptoms as measured 
by the BDI-II.  Overall, the present sample was relatively healthy, apparently high 
functioning, and generally symptom free, both in regard to cognitive and emotional 
functioning.  Additional analyses showed similar levels of health and well-being among 
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the nine HIV+ individuals who were excluded from participation in the study.  This 
indicated that the lack of neuropsychological symptomatology in our sample was not a 
mere consequence of the exclusionary criteria applied in the current study.  Moreover, the 
mean age of the sample was approximately 55 and therefore it may be that many 
individuals in the present sample were not yet old enough or had not been HIV+ long 
enough to begin to experience significant sequelae in regard to cognitive or emotional 
functioning.  
Another possibility is that the persons in the present sample were actively 
pursuing treatment regimens that were in fact yielding health benefits, both cognitively 
and emotionally.  The low prevalence of moderate to severe depression (16.3%) and the 
average executive functioning performance scores found in our HIV+ sample may reflect 
the advances of HIV care in the post-HAART era.  Moreover, our sample was found to 
be relatively healthy, with an average CD4 count of 190.  The sample showed less 
immune system compromise than found in previous studies of HIV+ individuals, 
suggesting that perhaps their disease processes and/or symptoms are being effectively 
managed.  The relatively high level of functioning within our sample could therefore 
represent evidence of the positive outcomes related to HIV treatment advances.  It may 
also be that in our sample of relatively healthy, middle-aged HIV+ persons, any cognitive 
deficits that did exist may have been too subtle to detect with the methods used in the 
current study.      
Limitations 
Overall, we did not find any significant association between apathy and executive 
functioning in a sample of HIV+ individuals.  This is in contrast to findings by Castellon 
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and colleagues (2000; 2006) and other recent research showing a relationship between 
cognitive impairment and symptoms of apathy in neurologically impaired populations 
(Andersson & Bergedalen, 2002; McPherson et al., 2002; Zgaljardic et al., 2007).  The 
reason for the absence of any significant association between apathy and executive 
functioning is unclear, but may be due to the methodology employed in the present study.  
Castellon and colleagues (2006) were able to break down the BDI to suggest that there is 
an aspect of depression, similar to apathy, which is more likely to reflect potential 
neurologic involvement.  Their subset of seven BDI items was defined as a Mood-
Motivation Disturbance factor and it included several items reflective of apathy, as well 
as items addressing sad mood and irritability.  However, most other studies showing a 
relationship between apathy and cognitive functioning have used independent, validated 
measures of apathy, such as the Neuropsychiatric Inventory (NPI; Cummings et al., 
1994).  Therefore, it is suspected that a limitation of the present study was that our apathy 
variable lacked construct validity and the four BDI-II items we selected failed to 
adequately capture the construct of apathy.  It may be that the four BDI-II items chosen 
to represent apathy in the present study accounted for too few of the many characteristics 
that define true apathy.  It is also possible that those items were in fact measuring 
symptoms of depression rather than apathy.  Our study failed to utilize an independent, 
validated criterion measure of apathy to determine whether the four BDI-II items in fact 
measured apathy.  The results of the present study are therefore somewhat inconclusive.  
Of note, there was a slight difference, right at the threshold of statistical 
significance, in estimated pre-morbid intellectual functioning (i.e., WTAR scores) 
between the Low Apathy and High Apathy subjects.  The High Apathy subjects were 
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found to have a lower mean WTAR score (93.49) than the Low Apathy group (101.16).  
This finding suggests that pre-morbid intelligence may be a factor (beyond neurotropic 
effects of HIV) that is related to psychiatric symptomatology such as apathy or 
depression.  This finding also reflects the limitation of the non-experimental archival 
nature of the current study in which the researcher could not manipulate variables and 
explore causal relationships.  For example, it is possible that some of the psychiatric 
symptoms and/or frontal/cognitive deficits were pre-existing risk factors leading to HIV 
contraction, and therefore predated the HIV infection and associated neuropsychiatric 
sequelae.   
As mentioned, a limitation of the current study was that it only utilized the BDI-II 
as a measure of depressive and apathy symptoms.  The self-reported assessment of 
symptoms of depression and/or apathy on the BDI-II was not corroborated by any other 
assessment measures or by diagnostic interviews.  In the original study, there was no 
assessment of apathy or depression based on third-party informants (e.g., romantic 
partners, family members, etc.).  Alas, the participants may not have been fully reliable 
informants in regard to their mood symptoms.  It is possible that some participants may 
not have been able to accurately perceive or have adequate insight to report on their 
levels of apathy or depression symptoms.  Of note, 72% of the sample fell in the non-
depressed range.  This finding was surprising and not consistent with the relatively high 
prevalence of depression found among most HIV+ populations that have been studied to 
date (e.g., Basu et al., 2005; Bing et al., 2001; Chandra et al., 2005; Treisman et al., 
1998).  One plausible explanation for the low levels of depressive symptoms identified 
within our sample was the self-report measure utilized.  For example, approximately 33% 
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of the current sample obtained total scores in the range of 0-4 on the BDI-II, suggesting 
the possibility that some of the sample may have been denying depression, or failing to 
put forth optimal effort when completing the measure.  These findings therefore raise 
questions about the adequacy of using only a self-report measure to assess for the 
presence of symptoms of depression and apathy in a community sample of HIV+ 
individuals.  However, the possibility that the present sample, which was relatively small, 
consisted of an unusual number of persons who were in fact relatively free of depressive 
symptoms must also be considered.   
Another limitation was the method by which the construct of apathy was 
determined for the present study.  Perhaps in part because there were only four BDI-II 
items utilized to represent apathy, there was a lack of variance between those groups who 
scored low and those who scored high on this variable.  Specifically, only 39.5% of our 
sample scored in the “High Apathy” range, while 48.9% of the sample scored in the 
“Low Apathy” range.  Therefore, there may have been insufficient representation of High 
Apathy subjects compared to Low Apathy subjects in the present sample.   
A lack of statistical power may also explain why we were unable to find 
differences between the Low Apathy and High Apathy groups.  Because we decided to 
exclude participants who recently abused substances, and split groups using approximate 
33%/67% cut-offs, this yielded a relatively small sample size (n = 83), which may have 
reduced the level of power for detecting executive function score differences between 
Low Apathy and High Apathy individuals.   
It is worth mentioning that one of the four executive function tests (i.e., Stroop C) 
included in the composite executive functioning performance score was demographically 
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adjusted solely based on age (Golden, 1978), due to a lack of demographic specific 
norms.  Therefore, the overall executive functioning score was not fully free from 
potentially significant comorbid factors, including gender, ethnicity, and years of 
education.  Moreover, in regard to executive function scores, in the current study there 
was no analysis to control for those individuals who may have substituted speed for 
accuracy.  Therefore, there may have been individuals who were speedy and therefore 
had higher T scores, despite having made a significant number of errors.  Failing to 
account for such errors in our analysis may have compromised the effectiveness of our 
composite score to adequately capture true executive functioning abilities.      
In addition, there were a number of limitations in regards to generalizability.  
First, because of the relatively small number of participants in the current study (N = 95), 
the findings may not generalize to the greater population of HIV-infected patients.  
Second, the data were collected in one geographic area and therefore the results may not 
be generalizable to older HIV+ persons living in other settings.  Third, because the 
current research study examined a population of HIV+ individuals without neurological 
comorbidities, the results cannot be generalized to an HIV+ population that is expected to 
have a significant number of such comorbid conditions.  Finally, the majority of the 
subjects in the original study were men, suggesting that the results may not be fully 
generalizable to women with HIV.   
Conclusions and Recommendations  
In summary, this study failed to find an association between a subset of BDI-II 
items thought to be reflective of apathy and executive functioning in a sample of older 
HIV+ individuals.  However, it will be important to further investigate the relevance of 
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apathy symptoms in samples of HIV-infected individuals, as well as among individuals 
from other neurologically compromised populations.  Based on the limitations of the 
current study, it is suggested that researchers utilize validated measures of apathy in any 
future research attempting to examine the relationship of apathy to cognitive functioning.  
It may be that a relationship between apathy and executive functioning would be found 
among older HIV+ persons if a more valid and robust measure of apathy were utilized.  
For example, adaptations of the apathy subscales of the Neuropsychiatric Inventory 
(NPI), developed by Cummings and colleagues (1994) and modified for use with HIV-
infected subjects (Castellon et al., 1998, 2000), may be among the leading measures to be 
considered for future studies.  Moreover, future research should assess apathy through 
multiple methods rather than rely solely upon self-report.  For example, the inclusion of 
ratings by clinicians and significant others may result in more comprehensive and 
accurate assessments of apathy.  
More research is needed on whether an apathy subscale can be identified from the 
BDI-II items.  The present study utilized the findings from earlier BDI research and 
rational analysis to select four items as the leading candidates for an apathy subscale.  
Future researchers might do well to step back and consider whether a broader or different 
set of BDI-II items could be selected as more promising and valid indicators of apathy 
among HIV+ persons.  Future research might also benefit from the inclusion of more 
HIV+ persons who display high levels of depressive symptoms, as well as more persons 
demonstrating significant cognitive problems.  Larger samples that have more variance 
on these critical dimensions of age and functioning may shed greater light on the 
relationship, if any, of apathy to executive functioning among HIV+ persons.  
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Despite the lack of findings in the present study, additional research is 
recommended to further investigate the relationship between the apathy component of 
depression and its relationship with neurocognitive performance and neurological 
functioning in an HIV+ population.  Further study is needed to clarify whether 
psychiatric features such as apathy may be a representative biomarker of HIV neurotropic 
effects on the CNS.  Understanding the connection between mood or motivation 
disturbance and markers of potential CNS involvement is important as it has potential 
implications for understanding the neurocognitive basis for neuropsychiatric 
symptomatology.  Ultimately, clarifying the connection between psychiatric 
symptomatology and neurological deficits may lead to the development of more optimal 
intervention efforts (e.g., neuro-protective therapies and psychopharmacological 
treatment options) for HIV+ individuals presenting with neuropsychological sequela.  
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